Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,091 | 17,933 | 21,316 | 23,637 | 27,061 |
| Other current assets | 125 | 147 | 432 | 259 | 64 |
| TOTAL | $29,216 | $18,080 | $21,748 | $23,896 | $27,125 |
| Non-Current Assets | |||||
| PPE Net | 156 | 34 | 7 | 8 | 7 |
| Intangibles | 41,737 | 42,280 | 0 | 0 | 0 |
| Other Non-Current Assets | 115 | 0 | 0 | 0 | 0 |
| TOTAL | $42,009 | $42,314 | $7 | $8 | $7 |
| Total Assets | $71,225 | $60,394 | $21,755 | $23,904 | $27,132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 908 | 1,049 | 1,421 | 1,435 | 2,615 |
| Accrued Expenses | 146 | N/A | 48 | 27 | 23 |
| TOTAL | $1,054 | $1,049 | $1,470 | $1,462 | $2,638 |
| Non-Current Liabilities | |||||
| TOTAL | $11,600 | $12,143 | $N/A | $N/A | $N/A |
| Total Liabilities | $12,654 | $13,192 | $1,470 | $1,462 | $2,638 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 891 | 887 | 724 | 390 | 390 |
| Common Shares | 11 | 377 | 373 | 392 | 373 |
| Retained earnings | -135,512 | -129,283 | -118,263 | -115,793 | -111,723 |
| TOTAL | $58,571 | $47,202 | $20,285 | $22,442 | $24,494 |
| Total Liabilities And Equity | $71,225 | $60,394 | $21,755 | $23,904 | $27,132 |